Today: 8 November 2025
Subscribe
Ondas Holdings (ONDS) News Today — Nov. 8, 2025: Lock‑Up Expiry, Sentrycs Deal Momentum, and Q3 Results Preview
 ·  ·  ·  ·  · 

Ondas Holdings (ONDS) News Today — Nov. 8, 2025: Lock‑Up Expiry, Sentrycs Deal Momentum, and Q3 Results Preview

by
8 November 2025
  • A 60‑day shareholder lock‑up tied to Ondas’ September financing expires today (Nov. 8)—a potential liquidity event traders are watching. [1]
  • The company reports Q3 2025 on Thursday, Nov. 13 at 8:30 a.m. ET, with a live call and webcast. [2]
  • Earlier this week, Ondas announced a definitive agreement to acquire Sentrycs, expanding its counter‑UAS portfolio and global reach. [3]
  • Friday’s stock action: ONDS closed $5.81 (+10.67%), with after‑hours indications near $6.39 and heavy volume flagged by several outlets. [4]
  • Zacks highlighted ONDS as its “Bull of the Day” on Friday, adding visibility ahead of earnings. [5]

What changed today (Nov. 8)

Lock‑up expiration arrives

A 60‑day lock‑up covering executive officers, directors and certain significant stockholders—tied to Ondas’ September 9 prospectus supplement—expires today. Market notices published late Friday flagged the lock‑up on warrants, options and RSUs as ending on Nov. 8, 2025. Practically, that can add tradable supply and sometimes amplifies near‑term volatility, though it doesn’t mandate selling. [6]

If you want the primary source: Ondas’ September 8‑K includes the form of lock‑up agreement, which sets a “period ending 60 days after the date of the Prospectus.” With the prospectus supplement dated Sept. 9, the 60‑day clock points to Nov. 8. [7]

This week at a glance

Sentrycs acquisition strengthens counter‑UAS stack

On Nov. 4, Ondas said it signed a definitive agreement to acquire Sentrycs, an Israel‑based leader in Cyber‑over‑RF counter‑drone technology deployed in 25+ countries. Management positioned the deal as a “detect‑to‑defeat” complement to Iron Drone Raider, broadening Ondas’ full‑spectrum C‑UAS offering; the company expects closing in November. [8]

Earnings date is set: Nov. 13

Ondas will report Q3 2025 results on Thursday, Nov. 13 at 8:30 a.m. ET via conference call and webcast. Expect discussion on integration progress, order activity across defense and security markets, and any updates tied to recent strategic moves. Dial‑in and webcast links are posted on the IR site. [9]

Coverage spotlight boosted visibility

On Nov. 7, Zacks named Ondas (ONDS) “Bull of the Day,” citing its autonomous systems roadmap and counter‑UAS positioning heading into earnings—another catalyst that helped put the name on more watchlists into the weekend. [10]

Why the lock‑up matters now

  • Supply mechanics: When a lock‑up expires, previously restricted holders may sell, increasing float. That doesn’t guarantee selling, but it can influence short‑term price action. Friday’s outsized volume—well above average—suggests positioning ahead of today’s expiry. [11]
  • Context from the source document: The SEC‑filed lock‑up form (attached to Ondas’ Sept. 10 8‑K) explicitly bars sales for 60 days after the prospectus date, aligning with today’s timing. [12]
  • Offsetting fundamentals: In parallel, the Sentrycs deal (expected to close this month) and the Nov. 13 earnings event keep a pipeline of potential fundamentals‑driven news in view. [13]

What to watch into Thursday’s Q3 print

  1. Order momentum & pipeline in defense and security (including how Sentrycs could integrate with Iron Drone Raider). [14]
  2. Margins and cash runway following recent capital actions and any commentary on capital allocation. (Management typically covers this on calls.) [15]
  3. Backlog and deployments across Ondas Autonomous Systems and Networks, especially where customers are scaling autonomous security operations. [16]
  4. Share dynamics post‑lock‑up, including any insider or major‑holder disclosures in the days following expiry. [17]

The bottom line

For Nov. 8, 2025, the lock‑up expiration is the headline event for ONDS. It lands just as Ondas heads into an earnings week and builds momentum behind its Sentrycs acquisition, which, if closed this month as planned, would broaden the company’s counter‑UAS capabilities in a market seeing rising demand. Near‑term trading may be choppier around the expiry, but investors will quickly pivot to Thursday’s Q3 call for updates on orders, integration, and 2026 positioning. [18]

Sources

  • MarketScreener/S&P Capital IQ notices on Nov. 8 lock‑up end (warrants, options, RSUs). [19]
  • SEC filing (Form 8‑K, Sept. 10) with the Form of Lock‑Up Agreement (60‑day period). [20]
  • Ondas IR press release (Nov. 4): “Ondas to Acquire Sentrycs…” (deal scope, expected November close). [21]
  • Ondas IR press release (Nov. 5): Q3 2025 results call on Nov. 13 at 8:30 a.m. ET. [22]
  • Price & volume context: Yahoo Finance historical prices (Nov. 7 close & after‑hours) and MarketBeat intraday recap. [23]
  • Zacks “Bull of the Day” coverage (Nov. 7), via Nasdaq syndication. [24]

Editor’s note: It is not investment advice.

Ondas Holdings (ONDS) Q3 Earnings Preview | Major Updates, Partnerships & Giveaway!
Watch this video on YouTube.

References

1. www.marketscreener.com, 2. ir.ondas.com, 3. ir.ondas.com, 4. finance.yahoo.com, 5. www.nasdaq.com, 6. www.marketscreener.com, 7. ir.ondas.com, 8. ir.ondas.com, 9. ir.ondas.com, 10. www.nasdaq.com, 11. www.marketbeat.com, 12. ir.ondas.com, 13. ir.ondas.com, 14. ir.ondas.com, 15. ir.ondas.com, 16. ir.ondas.com, 17. www.marketscreener.com, 18. www.marketscreener.com, 19. www.marketscreener.com, 20. ir.ondas.com, 21. ir.ondas.com, 22. ir.ondas.com, 23. finance.yahoo.com, 24. www.nasdaq.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Medical Properties Trust (MPW) Today: $150M Buyback, Fresh 10‑Q, and New Institutional Buying — Nov. 8, 2025
  2. Tenaya Therapeutics (TNYA) on Nov. 8, 2025: FDA Places Clinical Hold on TN‑201 Trial as AHA 2025 Showcases Encouraging MyPEAK‑1 Data
  3. Enterprise Products Partners (EPD) news today (Nov. 8, 2025): Institutions add to stakes, valuation debate heats up, and dividend payment approaches
  4. Archer Aviation (ACHR) today, Nov. 8, 2025: Hawthorne Airport deal, $650M equity raise, Q3 results—and why the stock slid

Stock Market Today

  • Evercore ISI Boosts Expedia Target to $350, Signaling Upside for EXPE
    November 8, 2025, 3:32 PM EST. Evercore ISI raised Expedia Group's target price from $280 to $350 and kept an outperform rating, implying about a 32.71% upside from current levels. The move comes as EXPE has seen a broad mix of broker coverage, with KeyCorp initiating coverage, Susquehanna and Oppenheimer lifting targets, Mizuho and Bank of America maintaining neutral to buy views. MarketBeat data show a Hold consensus at EXPE with an average price target of about $244.03, despite a Friday rally that pushed shares to roughly $263.73 and a 20% intraday gain. Key metrics cited include a debt-to-equity of 2.14, a 50-/200-day moving average trend higher, and a quarterly EPS beat of $7.57 on $4.41B revenue. Analysts expect roughly $12.28 EPS for the current year, reinforcing the bull case for Expedia.
  • Truist Trims Diodes DIOD Target to $51; Rating Stays Hold
    November 8, 2025, 3:30 PM EST. Truist Financial lowered its Diodes (DIOD) price target from $54 to $51 while keeping a Hold rating. The target implies about 15% upside from Friday's close of $44.33. The stock slid to $44.33 on volume of 416,733. Market cap is $2.06B, with a P/E of 32.5 and beta of 1.65; 12-month high/low are $67.40 / $32.93. Analysts' views are mixed: Weiss Ratings Hold (c-); Wall Street Zen upgraded to Buy; Zacks to Hold. MarketBeat shows a Moderate Buy consensus with a $54.33 target. DIOD last quarter delivered $0.74 EPS on $350.37M revenue. Insider activity included CFO Brett Whitmire selling 2,000 shares and SVP Emily Yang selling 1,000 shares.
  • Benchmark Trims DraftKings Target to $37 Amid Mixed Analyst Views (DKNG)
    November 8, 2025, 3:28 PM EST. DraftKings (DKNG) faced a pessimistic tilt from Benchmark, as the firm cut its price target from $43.00 to $37.00 while keeping a buy rating. The implied upside is about 25% from the prior close. Across the street, Morgan Stanley remains bullish with an overweight stance and a $52 target, and Mizuho lowered its target to $54 while signaling an outperform view. Susquehanna cut to $59 with a "positive" rating, and Weiss Ratings downgraded to sell. Bank of America moved from buy to neutral and slashed its target to $35. The Street's consensus sits at a Moderate Buy with an average target around $52.03 across 26 Buy, 2 Hold, 3 Sell. DKNG traded near $29.60, below its 50- and 200-day moving averages, after Q earnings miss.
  • Barclays Increases Montrose Environmental Group Target to $36, Upholds Overweight Rating
    November 8, 2025, 3:26 PM EST. Barclays raised its price objective for Montrose Environmental Group (NYSE: MEG) from $35.00 to $36.00 in a Friday note, while maintaining an overweight rating. The new target implies about a 38% upside from the prior close. MEG has drawn other calls, including JPMorgan Chase & Co. lifting its target to $33.00 and assigning a neutral rating; several analysts show a spectrum from Buy to Sell, with a MarketBeat consensus near Hold and an average target around $34.40. The stock traded around $26.08 on the day, with volume of about 178k against a typical 471k. Fundamentals show a negative net margin yet modest ROE; revenue beat estimates last quarter. Investors will watch how Barclays' raised target interacts with earnings guidance and broader sector sentiment.
  • Truist Lowers HubSpot (NYSE:HUBS) Target to $650; Mixed Analyst Stance on HUBS
    November 8, 2025, 3:24 PM EST. Truist Financial trimmed HubSpot (NYSE:HUBS) target from $675 to $650, while keeping a Buy rating. The move signals upside of about 60.9% from recent levels. Other analysts offered mixed guidance: KeyCorp cut to $650 (Overweight); Macquarie to $660 (Outperform); Barclays to $575 (Overweight); Wall Street Zen shifted HUBS to Hold; Citigroup raised to $658 (Buy). Market consensus remains a Moderate Buy with a roughly $626.50 average target per MarketBeat. In Friday trade, HUBS rose about 2.3% to $404 on above-average volume. The stock has posted a wide range this year; quarterly results beat with $2.66 EPS on $809.5 million revenue, though a negative net margin and stretched P/E persist. Investors watch ongoing price-target revisions and sentiment.
Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150
Previous Story

Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Realty Income (O) today: 665th monthly dividend, new 150M‑share ATM filing, and fresh Q3 2025 takeaways (Nov 8, 2025)
Next Story

Realty Income (O) today: 665th monthly dividend, new 150M‑share ATM filing, and fresh Q3 2025 takeaways (Nov 8, 2025)

Related Articles

Go toTop